1.Flatt, A, Pearce, N, Thomson, CD, Sears, MR, Robinson, MF & Beasley, R (1990) Reduced selenium in asthmatic subjects in New Zealand. Thorax 45, 95–99.
2.Rayman, MP (2000) The importance of selenium to human health. Lancet 356, 233–241.
3.Niskar, AS, Paschal, DC, Kieszak, SM, Flegal, KM, Bowman, B, Gunter, EW, Pirkle, JL, Rubin, C, Sampson, EJ & McGeehin, M (2003) Serum selenium levels in the US population: Third National Health and Nutrition Examination Survey, 1988–1994. Biol Trace Elem Res 91, 1–10.
4.Vogt, TM, Ziegler, RG, Patterson, BH & Graubard, BI (2007) Racial differences in serum selenium concentration: analysis of US population data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 166, 280–288.
5.World Health Organization (1987) Selenium. A Report of the International Programme on Chemical Safety. Environmental Health Criteria Series no. 58. Geneva: WHO.
6.Gao, S, Jin, Y, Hall, KS et al. (2007) Selenium level and cognitive function in rural elderly Chinese. Am J Epidemiol 165, 955–965.
7.Stone, WL, Stewart, ME, Nicholas, C & Pavuluri, S (1986) Effects of dietary selenium and vitamin E on plasma lipoprotein cholesterol levels in male rats. Ann Nutr Metab 30, 94–103.
8.Stone, WL, Scott, RL, Stewart, EM & Kheshti, A (1994) Lipoprotein alterations in the spontaneously hypertensive rat fed diets deficient in selenium and vitamin E. Proc Soc Exp Biol Med 206, 130–137.
9.Sengupta, A, Carlson, BA, Hoffmann, VJ, Gladyshev, VN & Hatfield, DL (2008) Loss of housekeeping selenoprotein expression in mouse liver modulates lipoprotein metabolism. Biochem Biophys Res Commun 365, 446–452.
10.Li, M, Cao, J & Sun, S (1991) Micro-fluorometric determination of trace amount of selenium in blood, hair and milk powder. Chinese J Public Health 10, 306–308.
11.Yang, M, Hendrie, HC, Hall, KS, Oluwole, OS, Hodes, ME & Sahota, A (1996) Improved procedure for eluting DNA from dried blood spots. Clin Chem 42, 1115–1116.
12.Hixson, JE & Vernier, DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31, 545–548.
13.Chen, J, Campbell, TC, Li, J & Peto, R (1990) Diet, Lifestyle and Mortality in China. Oxford/Ithaca, NY/Beijing: Oxford University Press/Cornell University Press/People’s Publishing House.
14.Cao, J, Chen, S & Sun, S (1993) A comparison of methods for estimating large population dietary fluoride intake in coal burning high fluoride communities. J Hyg Res 22, 52–54.
15.Zhai, F, Popkin, BM, Ma, L, Yu, W, Guo, X, Jin, S & Ge, K (1996) The evaluation of 24-hour individual dietary recall method in China. J Hyg Res 25, 51–56.
16.Cao, J, Yan, B & Zhang, S (1996) Relations between heavy exposure of selenium-fluoride and human health. J Hyg Res 25, 287–290.
17.He, L (2003) Summary for method and application of food frequency survey. J Foreign Med Sci: Hyg Sect 30, 368–371.
18.van den Brandt, PA, Goldbohm, RA, van’t Veer, P, Bode, P, Hermus, RJ & Sturmans, F (1993) Predictors of toenail selenium levels in men and women. Cancer Epidemiol Biomarkers Prev 2, 107–112.
19.Hunter, DJ, Morris, JS, Chute, CG, Kushner, E, Colditz, GA, Stampfer, MJ, Speizer, FE & Willett, WC (1990) Predictors of selenium concentration in human toenails. Am J Epidemiol 132, 114–122.
20.Virtanen, SM, van’t Veer, P, Kok, F, Kardinaal, AF & Aro, A (1996) Predictors of adipose tissue tocopherol and toenail selenium levels in nine countries: the EURAMIC study. European Multicentre Case–Control Study on Antioxidants, Myocardial Infarction, and Cancer of the Breast. Eur J Clin Nutr 50, 599–606.
21.Akbaraly, NT, Hininger-Favier, I, Carriere, I, Arnaud, J, Gourlet, V, Roussel, AM & Berr, C (2007) Plasma selenium over time and cognitive decline in the elderly. Epidemiology 18, 52–58.
22.Mahley, RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622–630.
23.Mahley, RW & Rall, SC Jr (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1, 507–537.
24.Weisgraber, KH & Mahley, RW (1996) Human apolipoprotein E: the Alzheimer’s disease connection. FASEB J 10, 1485–1494.
25.Talmud, PJ, Stephens, JW, Hawe, E, Demissie, S, Cupples, LA, Hurel, SJ, Humphries, SE & Ordovas, JM (2005) The significant increase in cardiovascular disease risk in APOEε4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4. Ann Hum Genet 69, 613–622.
26.Smith, JD, Miyata, M, Poulin, SE, Neveux, LM & Craig, WY (1998) The relationship between apolipoprotein E and serum oxidation-related variables is apolipoprotein E phenotype dependent. Int J Clin Lab Res 28, 116–121.
27.Jolivalt, C, Leininger-Muller, B, Bertrand, P, Herber, R, Christen, Y & Siest, G (2000) Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. Free Radic Biol Med 28, 129–140.
28.Miyata, M & Smith, JD (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides. Nat Genet 14, 55–61.
29.Shea, TB, Rogers, E, Ashline, D, Ortiz, D & Sheu, MS (2002) Apolipoprotein E deficiency promotes increased oxidative stress and compensatory increases in antioxidants in brain tissue. Free Radic Biol Med 33, 1115–1120.
30.Rosenblat, M & Aviram, M (1998) Macrophage glutathione content and glutathione peroxidase activity are inversely related to cell-mediated oxidation of LDL: in vitro and in vivo studies. Free Radic Biol Med 24, 305–317.
31.Mazur, A, Nassir, F, Gueux, E, Moundras, C, Bellanger, J, Grolier, P, Rock, E & Rayssiguier, Y (1996) Diets deficient in selenium and vitamin E affect plasma lipoprotein and apolipoprotein concentrations in the rat. Br J Nutr 76, 899–907.
32.Aviram, M, Maor, I, Keidar, S, Hayek, T, Oiknine, J, Bar-El, Y, Adler, Z, Kertzman, V & Milo, S (1995) Lesioned low density lipoprotein in atherosclerotic apolipoprotein E-deficient transgenic mice and in humans is oxidized and aggregated. Biochem Biophys Res Commun 216, 501–513.
33.Lavy, A, Brook, GJ, Dankner, G, Ben Amotz, A & Aviram, M (1991) Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism 40, 794–799.
34.Keidar, S, Kaplan, M, Shapira, C, Brook, JG & Aviram, M (1994) Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II. Atherosclerosis 107, 71–84.
35.Beaudeux, JL, Guillausseau, PJ, Peynet, J, Flourie, F, Assayag, M, Tielmans, D, Warnet, A & Rousselet, F (1995) Enhanced susceptibility of low-density lipoprotein to in vitro oxidation in type 1 and type 2 diabetic patients. Clin Chim Acta 239, 131–141.
36.Luoma, PV, Nayha, S, Sikkila, K & Hassi, J (1995) High serum α-tocopherol, albumin, selenium and cholesterol, and low mortality from coronary heart disease in northern Finland. J Intern Med 237, 49–54.
37.Zimmermann, C, Winnefeld, K, Streck, S, Roskos, M & Haberl, RL (2004) Antioxidant status in acute stroke patients and patients at stroke risk. Eur Neurol 51, 157–161.
38.Chang, CY, Lai, YC, Cheng, TJ, Lau, MT & Hu, ML (1998) Plasma levels of antioxidant vitamins, selenium, total sulfhydryl groups and oxidative products in ischemic-stroke patients as compared to matched controls in Taiwan. Free Radic Res 28, 15–24.
39.Virtamo, J, Valkeila, E, Alfthan, G, Punsar, S, Huttunen, JK & Karvonen, MJ (1985) Serum selenium and the risk of coronary heart disease and stroke. Am J Epidemiol 122, 276–282.